08 Sep Trial participants are heroes, let’s treat them that way
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
News
06 Sep The case for loosening trial eligibility reins
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
03 Sep Preventing Alzheimer’s disease
The UW School of Medicine and Public Health's Dr. Sterling Johnson recently joined Wisconsin Public Radio to discuss the Wisconsin Registry for Alzheimer's Prevention (WRAP) study at the University of Wisconsin-Madison....
01 Sep Alzheimer’s disease: Some trials to watch over the next year
The results of Eli Lilly's donanemab trial have lit a fire to Alzheimer's disease research but what else is on the horizon?...
01 Sep First Lady Dr. Jill Biden visits The Foundation For Black Women’s Wellness as part of her national Cancer Moonshot tour
Dr. Jill Biden participated in a listening session at the Foundation for Black Women’s Wellness on Madison’s West Side where she and U.S. Sen. Tammy Baldwin spoke on a panel with many of Madison and Milwaukee’s community health leaders highlighting the importance of early detection and...
31 Aug Pet dogs to the rescue!
Health-related discoveries in people can lead to better medical care for dogs. Likewise, studies of dog biology can lead to better understanding and treatments for people....
31 Aug Senator Baldwin, WEDC Secretary Hughes WIMR tour highlights UW–Madison collaborations, innovations in biohealth
Wisconsin Senator Tammy Baldwin recently visited the Wisconsin Institutes for Medical Research at UW–Madison, highlighting the university’s experience and expertise as a collaborative powerhouse in bioscience and technology....
31 Aug Single psilocybin dose again shows major depression benefit
Just one dose of psilocybin significantly improved depression symptoms and functional disability in patients with major depressive disorder (MDD), a randomized trial found....
30 Aug Faster drug approvals by FDA raise concerns about transparency and beneficence in clinical trials
Are faster drug approvals by the FDA hurting the public's overall perception of clinical research?...
29 Aug Psychedelic drug trial guidance: Commenters see vital role for psychotherapy
Commenters on the FDA's guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug administration from psychotherapy support, the proposed credentials for lead safety monitors and the agency’s characterization of the abuse potential of psychedelic drugs....